Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8784828 | Advances in Radiation Oncology | 2018 | 24 Pages |
Abstract
More than a third of patients diagnosed with incurable lung cancer receive palliative RT and 56% received >10 fractions. The use of RT varied by region and patient characteristics, and patients treated at freestanding RT centers were more likely to receive >10 fractions. Further research into factors that influence treatment decisions including potential financial incentives may contribute to the high value and strategic utilization of palliative RT.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Miranda B. MD, Ling MSPH, Angel MS, Deborah MD, MPH, Aileen B. MD, MPP,